02/13/2025
3:15 PM | Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics (Subject)
MSD Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
12/31/2024
4:10 PM | Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics, Inc. (Subject)
Alaunos Therapeutics (Subject)
Vieser Jaime (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
8:30 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
7:30 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
3:35 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Groenewald Ferdinand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
5:58 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K/A | |
07/16/2024
5:58 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K/A | |
07/16/2024
8:00 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
8:02 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
4:01 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
7:57 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
3:45 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
3:49 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024
3:52 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form ARS | |
04/15/2024
4:23 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form PRE 14A | |
04/01/2024
6:30 AM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2024
8:46 PM | Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics, Inc. (Issuer)
Alaunos Therapeutics (Issuer)
Groenewald Ferdinand (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/22/2024
3:44 PM | Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics, Inc. (Filer)
Alaunos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free TCRT Stock Alerts